Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RGC

Regencell Bioscience Holdings Ltd

CIK 0001829667 · Nasdaq

NasdaqHealth CareMedicinal Chemicals & Botanical Products
$6.07
↓ 0.42 (-6.47%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Options; Risks: Fundamentals, Technicals; Excluded: Ownership (no data)

Key stats

Market Cap
$3.00B
P/E Ratio
-837.44
EPS
-0.72
Dividend Yield
Not covered
52W Position
1%
Beta
1.31

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
617.57
P/S
Not covered
EV/Revenue
Not covered
ROE
-73.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$5.17$69.00

Latest Financials

2025-06-30 FY
Revenue
–
Net Income
-$3.58M
Total Assets
$5.76M
Free Cash Flow
-$3.27M

Recent news